What are reasons Korean pharmas rarely develop novel drugs on their own?
Korean pharmaceutical companies have rarely produced self-developed novel drugs.
According to the Ministry of Food and Drug Safety(MFDS), since ‘Sunpla Inj,’ a SK Chemicals’ anticancer drug, acquired approval as the first Korean drug in 1999, total 28 products have been approved as Korean drug ...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
